Literature DB >> 6941260

13C NMR study of gluconeogenesis from labeled alanine in hepatocytes from euthyroid and hyperthyroid rats.

S M Cohen, P Glynn, R G Shulman.   

Abstract

Metabolism of [3-13C]alanine in the presence and absence of beta-hydroxybutyrate or ethanol has been followed at 25 degrees C by 13C NMR at 90.5 MHz in primary hepatocytes from untreated rats and rats treated with triiodothyronine and not allowed to eat for 24 hr. The phosphoenolpyruvate/pyruvate futile cycle was followed in situ by comparing the concentration of 13C at the scrambled alanine C2 position with that at glucose C5. In the absence of ethanol, the flux through pyruvate kinase was 60% of the gluconeogenic flux in hepatocytes from hyperthyroid rats, compared with 25% in the controls. Incubation with ethanol reduced the pyruvate kinase flux in the hyperthyroid state to that measured in the controls. Under all conditions, the relative concentration of label at the aspartate C2 and C3 sites was 1:2, whereas at the corresponding carbons in glutamate, randomization was almost complete. These observations, which require flux of unscrambled label into aspartate, are consistent with intramitochondrial synthesis of aspartate only if there is incomplete mixing of the intramitochondrial oxaloacetate pool. The 13C enrichment measured in the ketone bodies is increased by the presence of exogenous beta-hydroxybutyrate. The greater labeling that we observe at C2 of beta-hydroxybutyrate compared with C4 under this condition is explained by the flow through 3-hydroxy-3-methylglutaryl-coenzyme A synthase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941260      PMCID: PMC318989          DOI: 10.1073/pnas.78.1.60

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Effect of thyroxine and 5,5-diphenyl-2-thiohydantoin on enzyme activities of rat liver and kidney.

Authors:  D G Colton; M A Mehlman; W R Ruegamer
Journal:  Endocrinology       Date:  1972-06       Impact factor: 4.736

2.  Rapid reciprocal changes in rat hepatic glycolytic enzyme and fructose diphosphatase activities following insulin and glucagon injection.

Authors:  O D Taunton; F B Stifel; H L Greene; R H Herman
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

3.  Fluctuation of hepatic enzymes important in glucose metabolism in relation to thyroid function.

Authors:  I Böttger; H Kriegel; O Wieland
Journal:  Eur J Biochem       Date:  1970-04

4.  Paths of carbon in gluconeogenesis and lipogenesis: the role of mitochondria in supplying precursors of phosphoenolpyruvate.

Authors:  H A Lardy; V Paetkau; P Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1965-06       Impact factor: 11.205

5.  Hormonal regulation of liver pyruvate kinase concentration and activity.

Authors:  M L Johnson; C M Veneziale
Journal:  Biochemistry       Date:  1980-05-13       Impact factor: 3.162

6.  Inhibition and alternate-substrate studies on the mechanism of malic enzyme.

Authors:  M I Schimerlik; W W Cleland
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

7.  Effects of hypo- and hyper-thyroidism on liver composition, blood glucose, ketone bodies and insulin in the male rat.

Authors:  A Aranda; E Montoya; E Herrera
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

8.  Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3'-5'-monophosphate, and insulin in the perfused rat liver.

Authors:  J B Blair; M A Cimbala; J L Foster; R A Morgan
Journal:  J Biol Chem       Date:  1976-06-25       Impact factor: 5.157

9.  Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes.

Authors:  J E Feliú; L Hue; H G Hers
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Gluconeogenesis in the kidney cortex. Flow of malate between compartments.

Authors:  R Rognstad
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

View more
  12 in total

1.  Magnetic resonance imaging. Part II--Clinical applications.

Authors:  W R Hendee; C J Morgan
Journal:  West J Med       Date:  1984-11

Review 2.  Nuclear magnetic resonance spectroscopy in diagnostic and investigative medicine.

Authors:  G I Shulman; J R Alger; J W Prichard; R G Shulman
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Response to burgess.

Authors:  Douglas E Befroy; Richard G Kibbey; Rachel J Perry; Kitt Falk Petersen; Douglas L Rothman; Gerald I Shulman
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

Review 4.  New advances in MR-compatible bioartificial liver.

Authors:  Rex E Jeffries; Jeffrey M Macdonald
Journal:  NMR Biomed       Date:  2011-02-20       Impact factor: 4.044

5.  Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; D Smith; C M Johnson; J B Blair; R G Shulman; R A DeFronzo
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

6.  In vivo carbon-13 nuclear magnetic resonance studies of heart metabolism.

Authors:  K J Neurohr; E J Barrett; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  tcaSIM: A Simulation Program for Optimal Design of 13C Tracer Experiments for Analysis of Metabolic Flux by NMR and Mass Spectroscopy.

Authors:  Jeffry R Alger; A Dean Sherry; Craig R Malloy
Journal:  Curr Metabolomics       Date:  2018

8.  Effect of dexamethasone on gluconeogenesis, pyruvate kinase, pyruvate carboxylase and pyruvate dehydrogenase flux in isolated hepatocytes.

Authors:  C G Jones; S K Hothi; M A Titheradge
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

9.  13C NMR studies of carbon metabolism in the hyphal fungus Aspergillus nidulans.

Authors:  C Dijkema; H C Kester; J Visser
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.

Authors:  G I Shulman; P W Ladenson; M H Wolfe; E C Ridgway; R R Wolfe
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.